What's in a name? An emerging framework for cancer-associated fibroblasts, myofibroblasts, and fibroblasts
- PMID: 36379205
- DOI: 10.1016/j.ccell.2022.10.018
What's in a name? An emerging framework for cancer-associated fibroblasts, myofibroblasts, and fibroblasts
Abstract
In this issue of Cancer Cell, Foster and colleagues explore the heterogeneity in cancer-associated fibroblasts (CAFs) across tissue types and species, and they identify mechanoresponsive (MR), immunomodulatory (IM), and steady-state-like (SSL) CAFs. They show that altering the relative abundance of these CAF subtypes influences tumor progression and response to anti-tumor therapy.
Crown Copyright © 2022. Published by Elsevier Inc. All rights reserved.
Conflict of interest statement
Declaration of interests The authors declare no competing interests.
Comment on
-
Multiomic analysis reveals conservation of cancer-associated fibroblast phenotypes across species and tissue of origin.Cancer Cell. 2022 Nov 14;40(11):1392-1406.e7. doi: 10.1016/j.ccell.2022.09.015. Epub 2022 Oct 20. Cancer Cell. 2022. PMID: 36270275 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Medical